First Study in Iraq About (HLA)-Drb1 * 15:01 as a Genetic Risk Factor for MS Initiation

1Alaa Hassan Khaliel, 2Ahmed Abdul- Hassan Abbas, 3Anmar Oday Hatem 1Ministry of Health, Baghdad, Iraq; 2College of Medicine, Al-Nahrain University, Baghdad, Iraq; 3Baghdad Teaching Hospital, Baghdad, Iraq Background: To assess the genotypes of (HLA)-DRB1 * 15:01 as genetic risk factor for MS development in samples of Iraqi MS patients. Material(s) and Method(s): This Case control…

Evaluation of Anti-JVC Antibody Index Evolution in Patients with Multiple Sclerosis

1Amal Atrous, 1Saloua Mrabet, 1Amira Souissi, 1Lilia Hmissi, 1Firas Larnoaout, 1Mouna Ben Djebara, 1Amina Gargouri, 1Imen Kacem, 1Riadh Gouider 1Department of Neurology, Clinical Investigation Centre Neurosciences and Mental Health, University Hospital Razi, Manouba, Tunisia; 2Faculty of medicine, University Tunis El Manar, Tunis, Tunisia Background: Anti- John Cunningham virus (JCV) antibody index has been reported to…

Prevalence of MS in Tehran, Iran in 2020 and Its Forecast for the Next 10 Years

1Sharareh Eskandarieh, 1Mohammad Ali Sahraian, 1Saeideh Ayoubi 1Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran Background: The Middle-east and North Africa (MENA) region had a high prevalence of MS between 1970 and 2015 (1-2). Iran had the highest prevalence of MS among the countries of the Eastern Mediterranean region (72.11/100000)…

Water-Pipe and Cigarette Smoking, Drug Abuse and Alcohol Consumption and the Risk of Primary Progressive Multiple Sclerosis: A Population Based Case-Control Study

1Sharareh Eskandarieh, 1Seyyed Hosein Mortazavi, 2Amir Almasi-Hashiani, 1Abdorreza Naser Moghadasi, 1Mohammad Ali Sahraian 1Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran; 2Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran Background: Multiple sclerosis is a chronic central nervous system disease and primary progressive multiple sclerosis (PPMS)…

Epidemiology of Multiple Sclerosis in Iraq: Retrospective Review of 4355 Cases and Literature Review

5Hayder K Hassoun, 1Akram Al Mahdawi, 2Nawfal Shaheed, 3Amanj Jamal, 4Sara Sami 1Faculty of Medicine, Baghdad University, Baghdad, Iraq; 2Baghdad Teaching Hospital, Baghdad, Iraq; 3Hawler Teaching Hospital, Erbil, Iraq; 4Marjan teaching hospital, bayblon, Iraq; 5Faculty of Medicine, Kufa University, Annajaf Al ashraf, Iraq Background: Multiple sclerosis (MS) is a progressive demyelinating and degenerative disease of…

Multiple Sclerosis During Pregnancy: Data from the MS Clinic in Benghazi Medical Center

1Anwaar Mukhtar Bennour, 1Majda Elshukri, 1Naziha Amer, 1Heba Elzawawi, 1Rabha Elsahli, 1Abdelhamid Elzawawi 1Benghazi Medical Center, Benghazi, Libya Background: There are many misconceptions about multiple sclerosis (MS) and pregnancy with issues surrounding disease modifying therapies (DMTs) remains a regular subject of discussion. Objective(s): To explore a local practice experience regarding management of women with MS…

COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience

1,2Raed Alroughani, 3,4Jasem Al-Hashel, 3Fathi Abokalawa, 4Malak Almojel, 3,5Samar Farouk Ahmed 1Amiri Hospital, Kuwait City, Kuwait; 2MS clinic, Ibn Sina Hospital, Kuwait City, Kuwait; 3Neurology Department, Ibn Sina hospital, Kuwait City, Kuwait; 4Kuwait University, Kuwait City, Kuwait; 5Minia University, Minia, Egypt Background: Two vaccine (BNT162b2 and ChAdOx1 nCoV-19) have been approved to be used in…

Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East

1Raed Alroughani, 2Jihad Said Inshasi, 3Jasem Al-Hashel, 4Jaber Alkhaboury, 4Abdullah Alsalti, 2Reem Al Suwaidi, 5Loqman H. Hassino, 6,7Samar Farouk Ahmed 1Division of Neurology, Department of Medicine, Amiri Hospital, Kuwait City, Kuwait; 2Neurology Department, Rashid Hospital and Dubai Medical College, Dubai, United Arab Emirates; 3Faculty of Medicine, Kuwait University, Kuwait City, Kuwait; 4Neurology Unit, College of…

Challenges of MS Patients for Receiving Health Care Services

1Sharareh Eskandarieh, 1Niloofar Jahromi, 1Narges Systena, 1Mohhamed Ali Sahraian 1Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran Background: Multiple sclerosis (MS) is a debilitating non-traumatic neurological disorder in young adults and can reduce quality of life (QoL) by interfering with work ability, leisure activities, and routine living tasks (1). Various…

Familial MS in the South Caspian Sea

1Seyedmohammad Baghbanian, 1Hadis Alinejad, 2Sharareh Eskandarieh, 2Mohammadali Sahraian 1Mazandaran University Of Medical Sciences, Sari, Iran; 2Tehran University Of Medical Sciences, Tehran, Iran Background/Objective(s): Mazandaran is a Caspian province in the north of Iran and with a population of more than three million people. The Mazanderani people’s ancestors came from the Caucasus region, perhaps displacing an…